Using gel aromatherapy to relieve pain in patients with De Quervain disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of aromatherapy gel compared to traditional diclofenac gel for treating pain in patients with De Quervain disease, a condition characterized by inflammation of specific tendons in the wrist. The trial aims to provide an alternative treatment option that may have fewer undesirable effects than current therapies. Participants will be recruited from the Hand Surgery and Rheumatology Departments at Strasbourg University Hospitals, and will receive either the aromatherapy gel or the diclofenac gel. The study will assess pain relief and functional improvement in the affected wrist.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Male or female patient aged 18 to 75,
* Patient with unilateral De Quervain's tenosynovitis,
* Patient cared in the Hand Surgery Department, SOS Mains Emergency Department or Rheumatology Department of Strasbourg University Hospitals,
* Patient informed of the results of the prior medical examination,
* Informed consent signed by the patient,
* Patient affiliated to a health insurance social protection scheme or beneficiary,
* For a woman of childbearing potential, negative urine pregnancy test at the inclusion visit and maintenance of effective contraception throughout the study.

Exclusion Criteria:

* Pregnant or breastfeeding patient,
* Patient allergic to a component of the gel with essential oils, Dicloflenac®, NSAIDs, or one of the excipients
* Patient treated with oral non-steroidal anti-inflammatory drugs
* Patient with ongoing treatment with another ointment at the treatment application site (radial edge of the wrist)
* Patient with damaged skin, whatever the lesion: oozing dermatosis, eczema, infected lesion, burn or wound,
* Patient with atopic skin disease,
* Patient with epilepsy or with a history of epilepsy,
* Patient with a history of homolateral De Quervain's tenosynovitis, or having already had corticosteroid infiltrations in the 6 months before his inclusion on the ipsilateral side of the pathology,
* Patient with associated tendinopathies in the elbow or forearm region,
* Impossibility of giving the patient information (patient in an emergency situation, patient with difficulties of understandin, agitation of the patient),
* Patient under legal protection, under guardianship or curatorship.

Where it's running

• Service SOS Main
  Strasbourg, France Recruiting

Study contacts

• Study coordinator: Marie SCHWEBEL
• Email: marie.schwebel@chru-strasbourg.fr
• Phone: 03 68 76 53 40

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Comparing standard physiotherapy and eccentric exercises for de Quervain's disease treatment

  This study tests whether standard physiotherapy or a special exercise program can help people with de Quervain's disease feel less pain and improve their daily activities.

  Recruiting Istituto Ortopedico Rizzoli · Bologna · NCT06296472

• Comparing two types of steroid injections for De Quervain's Tenosynovitis

  This study is testing whether steroid injections given inside or outside the tendon sheath work better to relieve pain for people with De Quervain's Tenosynovitis.

  Recruiting Phase 4 University of California, Davis · Sacramento, California · NCT04895956

• Comparing two training methods for treating De Quervain Tenosynovitis

  This study is testing which of two training methods works better for people with De Quervain Tenosynovitis to help them feel better.

  Recruiting Foundation University Islamabad · Rawalpindi, Punjab Province · NCT06839690

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.